Skip to content

Home
Company
Services
Partners
Register
- Registration
News & Events
Resources
- Links
- Publications
- Documents
- Templates
- Company Media
- Login
Contact

Home
Company
Services
Partners
Register
- Registration
News & Events
Resources
- Links
- Publications
- Documents
- Templates
- Company Media
- Login
Contact

Archives

Archives

NEWS

OpGen Submits De Novo Request to the U.S. FDA for Unyvero Urinary Tract Infection (UTI) Panel
OpGen Announces Positive Top Line Data from Clinical Trial for Unyvero Urinary Tract Infection (UTI) Panel
InfanDx Tackles Early Detection of Hypoxic Ischemic Encephalopathy
OpGen Subsidiary Curetis and BioVersys Sign Collaboration Agreement for Clinical Trial Support – BV100/Rifabutin to Treat Carbapenem Resistant Acinetobacter baumannii (CRAB) Infections

GBC BLOG

Fred Hutch Unveils Results of New Blood Test That Detects Colon Cancer
Bacteria Subtype Linked to Growth in Up to 50% of Human Colorectal Cancers
KLAS Research U.S. Digital Pathology Report Confirms Philips As One of The Industry’s Leading Players
Pan-Cancer Study Reveals Epigenomic Drivers for Cancer Development and Progression

Precision Medicine Starts With Pathology: Pathologists at the Center of Collaboration

March 19, 2019

Posted in GBC Blog

113 Cherry Street, Suite #80042
Seattle, WA 98104-2205 USA
PHONE: +1 888 659 1221
FAX: +1 206 299 9895
EMAIL: info@globalbioclinical.com

Copyright © GLOBAL BIOCLINICAL

Scroll To Top